Table 3 Sleep quality, depression, anxiety and medications between RLS- and RLS+
From: Restless legs syndrome in end stage renal disease patients undergoing hemodialysis
| Â | Â | Patients with ESRD, N (%) | Â | |
|---|---|---|---|---|
RLS- (n = 109) | RLS+ (n = 28) | P- value | ||
PSQI | Â | 7 (4-10) | 11 (5.25-13) | 0.001 |
Sleep disorder | Â | 73 (67.0%) | 25 (89.3%) | 0.020 |
HADS-D | Â | 5 (1-9) | 3 (1-7) | 0.622 |
Depression | No symptom | 70 (64.2%) | 22 (78.6%) | 0.251 |
Suspicious | 20 (18.3%) | 1 (3.6%) | Â | |
Confirmed | 19 (17.4%) | 5 (17.9%) | Â | |
HADS-A | Â | 2 (0-4) | 3 (1-6.5) | 0.151 |
Anxiety | No symptom | 99 (91%) | 25 (89.3%) | 0.773 |
Suspicious | 6 (5.5%) | 1 (3.6%) | Â | |
Confirmed | 4 (3.7%) | 2 (7.1%) | Â | |
Medications | Anti-anemia Medicine | 85 (78.0%) | 23 (82.1%) | 0.631 |
Sedative hypnotics | 10 (9.2%) | 7 (25.0%) | 0.047 | |